Trial intelligence / Profile preview

Ticagrelor vs Clopidogrel Post-TAVR

NCT02486367Phase 4Completed

Sponsor
University Hospitals Cleveland Medical Center
Start
Jun 2015
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor in thrombosis, sponsored by University Hospitals Cleveland Medical Center. Started Jun 2015; status: completed.

02

Drugs

ticagrelor
03

Conditions

thrombosis

Beyond the preview

Go deeper on NCT02486367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02486367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call